Laura Maria Alcântara (Laura Alcântara, Laura M Alcântara)

Scopus Author ID Ciência ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 4

Top Topics

Trypanosoma Cruzi

Oxidative Stress

Top Venues

Tropical medicine and infectious disease

International journal of molecular sciences

Molecules (Basel, Switzerland)

Cellular microbiology

Universidade de São Paulo - USP

Universidade Estadual de Campinas - UNICAMP (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidade de São Paulo - USP Nov 01 2017

Brazil

Post doctoral fellow :: Microbiology

Education History

Universidade Estadual de Campinas - UNICAMP Mar 01 2013 - Aug 29 2017

Brazil

PHD

Publications

Laura Maria Alcântara, Thalita C S Ferreira, Vanessa Fontana, Eric Chatelain, Carolina Borsoi Moraes, Lucio H Freitas-Junior
A Multi-Species Phenotypic Screening Assay for Leishmaniasis Drug Discovery Shows That Active Compounds Display a High Degree of Species-Specificity. Molecules (Basel, Switzerland) 25 (11) (2020)
Gregory Pedroso Dos Santos, Fernanda Midori Abukawa, Normanda Souza-Melo, Laura Maria Alcântara, Paula Bittencourt-Cunha, Carolina Borsoi Moraes, Bijay Kumar Jha, Bradford S McGwire, Nilmar Silvio Moretti, Sergio Schenkman
Cyclophilin 19 secreted in the host cell cytosol by Trypanosoma cruzi promotes ROS production required for parasite growth. Cellular microbiology 23 (4) (2020)
Tanira Matutino Bastos, Milena Botelho Pereira Soares, Caio Haddad Franco, Laura Maria Alcântara, Lorenzo Antonini, Manuela Sabatino, Nicola Mautone, Lucio Holanda Freitas-Junior, Carolina Borsoi Moraes, Rino Ragno, Dante Rotili, Sergio Schenkman, Antonello Mai, Nilmar Silvio Moretti
Identification of Inhibitors to Trypanosoma cruzi Sirtuins Based on Compounds Developed to Human Enzymes. International journal of molecular sciences 21 (10) (2020)
Caio Haddad Franco, Laura Maria Alcântara, Eric Chatelain, Lucio Freitas-Junior, Carolina Borsoi Moraes
Drug Discovery for Chagas Disease: Impact of Different Host Cell Lines on Assay Performance and Hit Compound Selection. Tropical medicine and infectious disease 4 (2) (2019)